Endocyte Stock Price (NASDAQ:ECYT)

Add to My Stocks
$17.94 $0.88 (5.16%) ECYT stock closing price Aug 17, 2018 (Closing)
Prev Close* : $17.06
Market Cap:
Day Low: $17.1
52 Week Low: $1.17
Open: $17.1
Volume: -
Day High: $18.1
52 Week High: $18.10

Latest Stock Market News

Latest Articles

Endocyte News - From Partners

ECYT Stockcharts

View ECYT PE ratio, PS ratio stocks charts and compare with peers.
ECYT Chart
Note: Compare Endocyte stock price history with the index and industry peers.

Endocyte Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Endocyte Returns

(return on equity)

Endocyte Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

ECYT Industry Peers

Company Price Change (%)
Therapeuticsmd (TXMD)5.390.16 (2.88%)
Furiex Pharmaceuticals (FURX)104.770 (0%)
Lantheus Holdings (LNTH)13.450.3 (2.18%)
Sumitomo Chemcl (SOMMY)27.730.08 (0.29%)
Eli Lilly (LLY)105.551.19 (1.14%)
Incyte (INCY)68.80.95 (1.4%)
Pfizer (PFE)42.090.67 (1.62%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ACER THERAPEUTS (ACER)28.942.7 (10.29%)
Tesaro Inc (TSRO)28.781.56 (5.73%)
Endocyte (ECYT)17.940.88 (5.16%)
Recro Pharma (REPH)6.120.3 (5.15%)
Achaogen (AKAO)5.920.24 (4.23%)
MOLECULAR TEMPL (MTEM)5.20.21 (4.21%)
Enanta Pharma (ENTA)92.583.19 (3.57%)
Top gainers from Medical-Drugs industry
* As of Aug 18, 2018
CompanyPriceChange (%)
Adamis Pharma (ADMP)2.450.38 (13.45%)
CTI BioPharma (CTIC)1.830.07 (3.68%)
Aratana Therapeutics (PETX)5.070.18 (3.43%)
Tetraphase Pharmaceuticals (TTPH)2.850.1 (3.39%)
United Therapeutics (UTHR)125.613.85 (2.97%)
Rigel Pharma (RIGL)2.620.08 (2.96%)
TherapeuticsMD (TXMD)5.390.16 (2.88%)
Top losers from Medical-Drugs industry
* As of Aug 18, 2018

Endocyte, Inc. Stock News - Partner Headlines

Endocyte Financial Statements

income statement20172016201520142013
Net Sales or Revenues---70.35M64.87M
Net Income-55.06M-43.88M-41.26M5.45M-18.03M
Total Operating Expense56.16M44.78M42.03M65.31M83.2M
View Endocyte income statement
balance sheet20172016201520142013
Total Assets100.76M143.49M178.38M212.8M162.85M
Total Liabilities5.27M6.34M7.03M7.79M74.62M
Shareholders Equity95.48M137.14M171.34M205M88.22M
View Endocyte balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.17M-1.4M-0.12M-58.16M-41.02M
Net Cash from (used by) Operating Activities-33.65M-34.65M-32.21M-42.2M-51.08M
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.71M-0.34M-1.49M-0.82M
View Endocyte cash flow statement

Endocyte Stock Message Board

An investor needs to spend $17.94 to buy ECYT stock, as the closing Endocyte stock price is $17.94. Endocyte market capitalization is $1.26B and it represents the total market value of ECYT stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Endocyte stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Endocyte is worth a lot, it will most likely be reflected in an inflated Endocyte stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 969,430 shares were traded with a closing stock price of $17.94 as of Aug 17, 2018, as can be seen from Endocyte stock quote. One can view Endocyte stock chart to follow the stock price trend. Endocyte paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of ECYT, view Endocyte stock price history.